Key result
T2a and T2b head and neck sarcomas linked to ~419% higher mortality versus smaller tumors.
Why the study?
Sarcomas in the head and neck are infrequent and heterogeneous, representing a small proportion of adult malignancies and head and neck cancers, with limited descriptive data available.
Cross-Sectional (n=62)
No
Relative Risk: 5.19 (95% CI 1.57–17.16)
p-value: p=0.002
Late diagnosis and advanced tumor characteristics (T2a/T2b, lymph node metastasis, invasion) are significantly associated with decreased survival in patients with head and neck soft-tissue sarcomas.
T2 tumors associated with worse survival in head and neck sarcomas; hypothesis-generating for staging refinements in prospective cohorts.
Sarcomas are infrequent and heterogeneous tumours.They represent 1-2% of all malignant neoplasms in adults and between 4% and 10% of head and neck cancers.Methods: The research was retrospective, descriptive, and cross-sectional.Results: A study population of 62 patients with a mean age of 44 years was obtained; the most frequent location was the soft tissues of the neck (25.3%) and the mean tumour size was 7.1 cm; the most frequent diagnosis was undifferentiated pleomorphic sarcoma (25.5%) and the majority were stage III (41.4%).The lowest survival rates were associated with T2a and T2b tumours (p = 0.014), the presence of lymph node metastasis (p = 0.001), advanced stages (p = 0.003), and invasion of bone, blood vessels and/or nerves (p = 0.008).Conclusions: Late diagnosis is the main factor associated with decreased survival in patients with head and neck sarcomas.
No takes yet. Share an insight, caveat, or question.
Liuzzi et al. (2017) conducted a cross-sectional in Soft-tissue sarcomas of the head and neck (n=62). T2a or T2b tumor classification vs. T1a or T1b tumor classification was evaluated on Overall survival (RR 5.19, 95% CI 1.57-17.16, p=0.002). In adults with head and neck soft-tissue sarcomas, T2a and T2b tumors were significantly associated with decreased overall survival compared to smaller tumors (RR 5.19).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: